In-Situ Forming Polymeric Drug Delivery Systems for Ophthalmic Use: An Overview

Delivery of drug into the ocular region is hindered by the protective layers that encapsulate the eyes, it has always been a major problem to get an effective bioavailability of the active drug in the ocular region due to the low precorneal resident time of most of the ocular delivery systems specifically convention once such as ointment, solution and suspension, as a result, most of the delivery systems are not capable of effectively treating ocular diseases. Several works have and are being carried out to overcome this problem one of which is using in-situ forming polymeric systems. Ocular In-situ gelling systems are a novel class of ocular drug delivery systems that are initially in a solution form but instantaneously gets converted into a viscous gel upon introduction or installation in the ocular cavity from which the active drugs get released in a sustained manner. This sol-togel phase transition depends upon various factors like change in pH, ion presence and change in temperature. Gel formed after the transformation has preferred viscosity along with bio-adhesive property, which increases the gel’s resident time in the ocular area and also releases the drug in a prolonged and sustained manner unlike conventional eye drops and ointments. This review emphasizes various ocular in-situ systems namely, pH triggered, Ion activated, and Temperature triggered systems which have prolonged residence time in the cul-de-sac area of the eye, hence increasing the ocular bioavailability.

[1]  Manisha Pandey,et al.  Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research , 2021, Polymers.

[2]  B. Padmasri,et al.  A COMPREHENSIVE REVIEW ON IN SITU GELS , 2020, International Journal of Applied Pharmaceutics.

[3]  F. Otero-Espinar,et al.  Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations , 2020, Pharmaceutics.

[4]  P. Prasanna Editorial note of American Journal of Drug Delivery and Therapeutics , 2020 .

[5]  K. Dua,et al.  Formulation and Characterization of pH Induced in situ Gels Containing Sulfacetamide Sodium for Ocular Drug Delivery: A Combination of Carbopol®/ HPMC Polymer , 2019, Indian Journal of Pharmaceutical Education and Research.

[6]  David S. Jones,et al.  Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. , 2019, Drug discovery today.

[7]  H. Wahab,et al.  IN SITU OPTHALMIC GEL WITH ION ACTIVATED SYSTEM , 2019, International Journal of Applied Pharmaceutics.

[8]  Upendra Nagaich,et al.  FORMULATION, OPTIMIZATION, AND EVALUATION OF IN-SITU GEL OF MOXIFLOXACIN HYDROCHLORIDE FOR OPHTHALMIC DRUG DELIVERY , 2019, International Journal of Applied Pharmaceutics.

[9]  Asmat Majeed,et al.  Ocular in situ gel: An overview , 2019, Journal of Drug Delivery and Therapeutics.

[10]  Yuanyuan Liu,et al.  Research progress of in-situ gelling ophthalmic drug delivery system , 2018, Asian journal of pharmaceutical sciences.

[11]  Myasar Al-kotaji,et al.  OPHTHALMIC IN-SITU SUSTAINED GEL OF CIPROFLOXACIN, PREPARATION AND EVALUATION STUDY , 2018, International Journal of Applied Pharmaceutics.

[12]  C. Sahoo,et al.  A Review on in situ Gel : A Novel Drug Delivery System , 2018 .

[13]  P. Sujit Formulation and characterization of thermosensitive in situ gel of moxifloxacin for ocular delivery , 2018 .

[14]  H. Mahajan,et al.  An insight to ocular in situ gelling systems , 2017 .

[15]  Animikh Ray,et al.  A comprehensive insight on ocular pharmacokinetics , 2016, Drug Delivery and Translational Research.

[16]  V. Patel,et al.  Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride , 2015, Results in pharma sciences.

[17]  A. Mitra,et al.  Ocular Drug Delivery , 1990 .

[18]  M. Amaral,et al.  In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. , 2014, Drug discovery today.

[19]  S. Bhujbal OCULAR DRUG DELIVERY SYSTEM: A REVIEW , 2014 .

[20]  P. Malik,et al.  pH-induced in situ gelling system of an anti-infective drug for sustained ocular delivery , 2014 .

[21]  Kamel Alhanout,et al.  Recent advances in ocular drug delivery , 2013, Drug development and industrial pharmacy.

[22]  A. Mitra,et al.  Ocular drug delivery systems: An overview. , 2013, World journal of pharmacology.

[23]  V. Hari,et al.  IN-SITU GELLING SYSTEM - POTENTIAL TOOL FOR IMPROVING THERAPEUTIC EFFECTS OF DRUGS , 2013 .

[24]  D. F. James,et al.  Generic versus brand-name North American topical glaucoma drops. , 2012, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[25]  M. Gadhave,et al.  DESIGN AND DEVELOPMENT OF pH - TRIGGERED IN SITU GELLING SYSTEM OF CIPROFLOXACIN , 2012 .

[26]  S. Harikumar,et al.  IN-SITU OPHTHALMIC GELS FOR THE TREATMENT OF EYE DISEASES , 2012 .

[27]  Arushi Gupta,et al.  In-Situ Gelling System : A Novel Approach for Ocular Drug Delivery , 2012 .

[28]  Agarwal Ki,et al.  In-Situ Gel Formation for Ocular Drug Delivery System an Overview , 2011 .

[29]  P. Shelat,et al.  Ophthalmic drug delivery system: Challenges and approaches , 2010 .

[30]  Eaga Chandra Mohan,et al.  Preparation and Evaluation of In-Situ-Gels for Ocular Drug Delivery , 2009 .

[31]  Pornsak Sriamornsak,et al.  Chemistry of Pectin and Its Pharmaceutical Uses : A Review , 2007 .

[32]  Arto Urtti,et al.  Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.

[33]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[34]  J. Sandford-Smith Basic Anatomy and Physiology of the Eye , 1990 .

[35]  N. R. Galloway,et al.  Common Eye Diseases and their Management , 1985 .